Stock info Cafom | Filter  Basic-Info

Cafom

Cafom primarily operates in the food & drug sector. The global food & drug retailers gained around 32 percent worldwide over the last 10 years. Measured since 2011 the sector is 27 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 32 percent.

The past year was a profitable year for Cafom investors

Over the period from December 2015 till December 2016 the stock lost around 7 percent. The period between August 2011 and August 2016 was a good period for the investors. The stock rose around 3 percent. Cafom's revenues between 2011 and 2015 were relatively stable and moved between 365,51 million euros and 384,54 million euros. Cafom's net incomes between 2011 and 2015 were very volatile through the time and moved between 0,12 million euros and 6 million euros.

The French company didn't pay out any dividends (in the past 5 years).

Cafom' balance mostly financed with equity

Last year the balance sheet of the French company was worth 337,47 million euros. The total debt was around 215,78 million euros. This is 63,94 percent of the total balance sheet. At the end of 2016 the French company was traded with a price/earnings-ratio of around 14. So investors paid 14 times the company's 2015's EPS. Based on it's price/earnings-ratio and dividend yield the French stock can be seen as a value stock.

At the end of 2015 the market capitalization (the number of shares outstanding multiplied by the stock price) of the food & drug retailer equaled around 75,73 million euros. At the end of 2015 around 8,51 million stocks were listed.

All Cafom's annual reports can be found here. More information about Cafom can be found it's website. .